Literature DB >> 30830427

Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harmonization of quality control standards.

Richard D Beger1.   

Abstract

Up to now, quality assurance (QA) and quality control (QC) in metabolomics are procedures that most labs did using their own in-house developed procedures and rules since there was no consensus or minimum requirement. Now there is a lot of enthusiasm for developing standardization of QA and QC procedures.

Entities:  

Keywords:  Biomarkers; Harmonizing QC standards; Metabolomics; Quality control

Year:  2018        PMID： 30830427     DOI： 10.1007/s11306-018-1453-6

Source DB:  PubMed          Journal:  Metabolomics        ISSN： 1573-3882            Impact factor:   4.290


  9 in total

1.  The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements.

Authors:  Leming Shi; Laura H Reid; Wendell D Jones; Richard Shippy; Janet A Warrington; Shawn C Baker; Patrick J Collins; Francoise de Longueville; Ernest S Kawasaki; Kathleen Y Lee; Yuling Luo; Yongming Andrew Sun; James C Willey; Robert A Setterquist; Gavin M Fischer; Weida Tong; Yvonne P Dragan; David J Dix; Felix W Frueh; Frederico M Goodsaid; Damir Herman; Roderick V Jensen; Charles D Johnson; Edward K Lobenhofer; Raj K Puri; Uwe Schrf; Jean Thierry-Mieg; Charles Wang; Mike Wilson; Paul K Wolber; Lu Zhang; Shashi Amur; Wenjun Bao; Catalin C Barbacioru; Anne Bergstrom Lucas; Vincent Bertholet; Cecilie Boysen; Bud Bromley; Donna Brown; Alan Brunner; Roger Canales; Xiaoxi Megan Cao; Thomas A Cebula; James J Chen; Jing Cheng; Tzu-Ming Chu; Eugene Chudin; John Corson; J Christopher Corton; Lisa J Croner; Christopher Davies; Timothy S Davison; Glenda Delenstarr; Xutao Deng; David Dorris; Aron C Eklund; Xiao-hui Fan; Hong Fang; Stephanie Fulmer-Smentek; James C Fuscoe; Kathryn Gallagher; Weigong Ge; Lei Guo; Xu Guo; Janet Hager; Paul K Haje; Jing Han; Tao Han; Heather C Harbottle; Stephen C Harris; Eli Hatchwell; Craig A Hauser; Susan Hester; Huixiao Hong; Patrick Hurban; Scott A Jackson; Hanlee Ji; Charles R Knight; Winston P Kuo; J Eugene LeClerc; Shawn Levy; Quan-Zhen Li; Chunmei Liu; Ying Liu; Michael J Lombardi; Yunqing Ma; Scott R Magnuson; Botoul Maqsodi; Tim McDaniel; Nan Mei; Ola Myklebost; Baitang Ning; Natalia Novoradovskaya; Michael S Orr; Terry W Osborn; Adam Papallo; Tucker A Patterson; Roger G Perkins; Elizabeth H Peters; Ron Peterson; Kenneth L Philips; P Scott Pine; Lajos Pusztai; Feng Qian; Hongzu Ren; Mitch Rosen; Barry A Rosenzweig; Raymond R Samaha; Mark Schena; Gary P Schroth; Svetlana Shchegrova; Dave D Smith; Frank Staedtler; Zhenqiang Su; Hongmei Sun; Zoltan Szallasi; Zivana Tezak; Danielle Thierry-Mieg; Karol L Thompson; Irina Tikhonova; Yaron Turpaz; Beena Vallanat; Christophe Van; Stephen J Walker; Sue Jane Wang; Yonghong Wang; Russ Wolfinger; Alex Wong; Jie Wu; Chunlin Xiao; Qian Xie; Jun Xu; Wen Yang; Liang Zhang; Sheng Zhong; Yaping Zong; William Slikker
Journal:  Nat Biotechnol       Date:  2006-09       Impact factor: 54.908

2.  A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis.

Authors:  Timothy Sangster; Hilary Major; Robert Plumb; Amy J Wilson; Ian D Wilson
Journal:  Analyst       Date:  2006-08-15       Impact factor: 4.616

Review 3.  Reproducible and reliable microarray results through quality control: good laboratory proficiency and appropriate data analysis practices are essential.

Authors:  Leming Shi; Roger G Perkins; Hong Fang; Weida Tong
Journal:  Curr Opin Biotechnol       Date:  2007-12-26       Impact factor: 9.740

Review 4.  Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology.

Authors:  R Kaddurah-Daouk; R M Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  2013-11-05       Impact factor: 6.875

5.  Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry.

Authors:  Warwick B Dunn; David Broadhurst; Paul Begley; Eva Zelena; Sue Francis-McIntyre; Nadine Anderson; Marie Brown; Joshau D Knowles; Antony Halsall; John N Haselden; Andrew W Nicholls; Ian D Wilson; Douglas B Kell; Royston Goodacre
Journal:  Nat Protoc       Date:  2011-06-30       Impact factor: 13.491

6.  Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism.

Authors:  T Andrew Clayton; David Baker; John C Lindon; Jeremy R Everett; Jeremy K Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

7.  Development and Application of Ultra-Performance Liquid Chromatography-TOF MS for Precision Large Scale Urinary Metabolic Phenotyping.

Authors:  Matthew R Lewis; Jake T M Pearce; Konstantina Spagou; Martin Green; Anthony C Dona; Ada H Y Yuen; Mark David; David J Berry; Katie Chappell; Verena Horneffer-van der Sluis; Rachel Shaw; Simon Lovestone; Paul Elliott; John Shockcor; John C Lindon; Olivier Cloarec; Zoltan Takats; Elaine Holmes; Jeremy K Nicholson
Journal:  Anal Chem       Date:  2016-08-26       Impact factor: 6.986

8.  Metabolomics enables precision medicine: "A White Paper, Community Perspective".

Authors:  Richard D Beger; Warwick Dunn; Michael A Schmidt; Steven S Gross; Jennifer A Kirwan; Marta Cascante; Lorraine Brennan; David S Wishart; Matej Oresic; Thomas Hankemeier; David I Broadhurst; Andrew N Lane; Karsten Suhre; Gabi Kastenmüller; Susan J Sumner; Ines Thiele; Oliver Fiehn; Rima Kaddurah-Daouk
Journal:  Metabolomics       Date:  2016-09-02       Impact factor: 4.290

Review 9.  Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies.

Authors:  David Broadhurst; Royston Goodacre; Stacey N Reinke; Julia Kuligowski; Ian D Wilson; Matthew R Lewis; Warwick B Dunn
Journal:  Metabolomics       Date:  2018-05-18       Impact factor: 4.290
  9 in total
  5 in total

Review 1.  Salivary metabolomics for the diagnosis of periodontal diseases: a systematic review with methodological quality assessment.

Authors:  Giacomo Baima; Giovanni Iaderosa; Filippo Citterio; Silvia Grossi; Federica Romano; Giovanni N Berta; Nurcan Buduneli; Mario Aimetti
Journal:  Metabolomics       Date:  2021-01-01       Impact factor: 4.290

2.  Closing the gap between in vivo and in vitro omics: using QA/QC to strengthen ex vivo NMR metabolomics.

Authors:  Amith Sadananda Maroli; Robert Powers
Journal:  NMR Biomed       Date:  2021-08-08       Impact factor: 4.044

Review 3.  Toward a Standardized Strategy of Clinical Metabolomics for the Advancement of Precision Medicine.

Authors:  Nguyen Phuoc Long; Tran Diem Nghi; Yun Pyo Kang; Nguyen Hoang Anh; Hyung Min Kim; Sang Ki Park; Sung Won Kwon
Journal:  Metabolites       Date:  2020-01-29

4.  Single Spheroid Metabolomics: Optimizing Sample Preparation of Three-Dimensional Multicellular Tumor Spheroids.

Authors:  Mate Rusz; Evelyn Rampler; Bernhard K Keppler; Michael A Jakupec; Gunda Koellensperger
Journal:  Metabolites       Date:  2019-12-14

Review 5.  Metabolomics in clinical and forensic toxicology, sports anti-doping and veterinary residues.

Authors:  Bethany Keen; Adam Cawley; Brian Reedy; Shanlin Fu
Journal:  Drug Test Anal       Date:  2022-03-08       Impact factor: 3.234
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.